# K130914: Filmarray Blood Culture Identification (Bcid) Panel - Pathway: 510(k) (Traditional) - Applicant: Biofire Diagnostics, Inc. - Decided: Jun 21, 2013 after 80 days - Product code: PEN (Gram-Negative Bacteria And Associated Resistance Markers) - Device class: 2 - Regulation: 21 CFR 866.3365 - Recalls of this device: 6 (0 Class I) - Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026 ## Lineage Longest line of descent: 2 generations back to DEN120014 (2012). 2 ancestors in all. 9 later devices descend from it; 4 cite it directly. 0 of 12 devices in its family (counting itself) have a Class I recall. ## Predicates on the family tree (from the FDA summary) - K122514: Verigene Gram-Positive Blood Culture (GC-GP) Nucleic Acid Test, Nanosphere, Inc. (2012) Summary page 1. ## Most influential descendants - K182690: ePlex Blood Culture Identification Panel Fungal Pathogen (BCID-FP) Panel (2018), 2 descendants of its own - K132843: Verigene Gram Negative Blood Culture Nucleic Acid Test (BC-GN) (2014), 2 descendants of its own - K181663: ePlex Blood Culture Identification Panel - Gram Positive (BCID-GP) Panel (2018), 1 descendant of its own - K143171: FilmArray Blood Culture Identification (BCID) Panel for use with the FilmArray 2.0 (2015), 1 descendant of its own - K254194: QIAstat-Dx BCID GPF Plus AMR Panel (2026), 0 descendants of its own ## Recalls of this device - Jan 22, 2020 · Class II · Z-2296-2020: There is an increased risk of false positive Proteus results when using the Film Array Blood Culture Identification Panel (BCID) in vitro diagnostic test of blood cultures used in conjunction with spe - Jan 22, 2020 · Class II · Z-2295-2020: There is an increased risk of false positive Proteus results when using the Film Array Blood Culture Identification Panel (BCID) in vitro diagnostic test of blood cultures used in conjunction with spe - Mar 7, 2019 · Class II · Z-1133-2019: Increased risk of false positive Enterobacteriaceae and Escherichia coli results on affected blood culture identification panels when using certain blood culture bottles. - Sep 5, 2018 · Class II · Z-0296-2019: Increased risk of false positive results for Proteus when the product is used with a specific blood culture bottles. - Mar 14, 2018 · Class II · Z-1513-2018: There is an increased risk of false positive Proteus results when the product is used with specific types of BD BACTEC blood culture bottles. - May 27, 2014 · Class II · Z-1843-2014: BioFire has identified an increased risk of false positive results when the FilmArray Blood Culture Identification (BCID) Panel is used with bioM¿rieux BacT/ALERT Standard Anaerobic (SN) blood culture ## Indications for use The FilmArray Blood Culture Identification (BCID) Panel is a qualitative multiplexed nucleic acid-based in vitro diagnostic test intended for use with the FilmArray Instrument. The FilmArray BCID Panel is capable of simultaneous detection and identification of multiple bacterial and yeast nucleic acids and select genetic determinants of antimicrobial resistance. The BCID assay is performed directly on blood culture samples identified as positive by a continuous monitoring blood culture system that demonstrates the presence of organisms as determined by Gram stain. The following gram-positive bacteria, gram-negative bacteria, and yeast are identified using the FilmArray BCID Panel: Enterococci, Listeria monocytogenes, commonly encountered Staphylococci (including specific differentiation of Staphylococcus aureus), commonly encountered Streptococci (with specific differentiation of Streptococcus agalactiae, Streptococcus pneumoniae, and Streptococcus pyogenes), Acinetobacter baumannii, commonly encountered Enterobacteriaceae (including specific differentiation of the Enterobacter cloacae complex, Escherichia coli, Klebsiella oxytoca, Klebsiella pneumoniae, Proteus, and Serratia marcescens), Haemophilus influenzae, Neisseria meningitidis (encapsulated), Pseudomonas aeruginosa, Candida albicans, Candida glabrata, Candida krusei, Candida parapsilosis, and Candida tropicalis. The FilmArray BCID Panel also contains assays for the detection of genetic determinants of resistance to methicillin (mec4), vancomycin (vand and vanB), and carbapenems (blakpc) to aid in the identification of potentially antimicrobial resistant organisms in positive blood culture samples. The antimicrobial resistance gene detected may or may not be associated with the agent responsible for disease. Negative results for these select antimicrobial resistance gene assays do not indicate susceptibility, as multiple mechanisms of resistance to methicillin, vancomycin, and carbapenems exist. FilmArray BCID is indicated as an aid in the diagnosis of specific agents of bacteremia and fungemia and results should be used in conjunction with other clinical and laboratory findings. Positive FilmArray results do not rule out co-infection with organisms not included in the FilmArray BCID Panel. FilmArray BCID is not intended to monitor treatment for bacteremia or fungemia. Subculturing of positive blood cultures is necessary to recover organisms for susceptibility testing and epidemiological typing, to identify organisms in the blood culture that are not detected by the FilmArray BCID Panel, and for species determination of some Staphylococci, Enterococci, Streptococci, and Enterobacteriaceae that are not specifically identified by the FilmArray BCID Panel assays. Source page: https://510kreport.com/device/K130914 Methodology: https://510kreport.com/methodology